Neuroone Medical Technologies is trading 7.91% down at $1.63, with no clear company-specific catalyst identified for the after-hours decline.
- It closed at $1.77 on August 28, 2026.
- The latest filing, reported August 27, concerned successful large-animal StereoCED procedures.
- The most recent quarterly results were released August 13; neither directly explains the August 28 move.